PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2022.8342023552542-550Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant ChemotherapyEun-Gyeong Lee, Dong-Eun Lee, Hyun hee Kim, Jai Hong Han, Seeyoun Lee, Han-Sung Kang, Eun Sook Lee, Heejung Chae, Sung Hoon Sim, Keun Seok Lee, Youngmee Kwon, So-Youn Junghttp://e-crt.org/upload/pdf/crt-2022-834.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2022.834, http://e-crt.org/upload/pdf/crt-2022-834.pdf
10.21203/rs.3.rs-806115/v12021Exploring the Influencing Factors of Pathologic Complete Response in Estrogen Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy: A Retrospective StudyLingfeng Tang, Xiujie Shu, Gang Tuhttps://www.researchsquare.com/article/rs-806115/v1, https://www.researchsquare.com/article/rs-806115/v1.html
BMC Cancer10.1186/s12885-020-07505-w2020201Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapyIn Hee Lee, Soo Jung Lee, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Shin Young Jeong, Sang-woo Lee, Yee Soo Chaehttp://link.springer.com/content/pdf/10.1186/s12885-020-07505-w.pdf, http://link.springer.com/article/10.1186/s12885-020-07505-w/fulltext.html, http://link.springer.com/content/pdf/10.1186/s12885-020-07505-w.pdf
10.21203/rs.3.rs-24641/v22020Utility of 18F-FDG PET/CT for predicting pathologic complete response in Hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapyIn Hee Lee, Soo Jung Lee, Jeeyeon Lee, Jinhyang Jung, Hoyong Park, Shin Young Jeong, Sang-woo Lee, Yee Soo Chaehttps://www.researchsquare.com/article/rs-24641/v2, https://www.researchsquare.com/article/rs-24641/v2.html
World Journal of Surgical Oncology10.1186/s12957-022-02787-92022201Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in ChinaDandan Guan, Qiu Jie, Yihao Wu, Yuhao Xu, Weimin Hong, Xuli Menghttps://link.springer.com/content/pdf/10.1186/s12957-022-02787-9.pdf, https://link.springer.com/article/10.1186/s12957-022-02787-9/fulltext.html, https://link.springer.com/content/pdf/10.1186/s12957-022-02787-9.pdf
Breast Cancer Research and Treatment10.1007/s10549-020-05883-020201843999-999Luminal subtypes and response to neoadjuvant chemotherapy for hormone receptor-positive HER2-negative patientsKadri Altundaghttps://link.springer.com/content/pdf/10.1007/s10549-020-05883-0.pdf, https://link.springer.com/article/10.1007/s10549-020-05883-0/fulltext.html, https://link.springer.com/content/pdf/10.1007/s10549-020-05883-0.pdf
Oncology10.1159/000526155202210010529-535Factors Affecting Pathologic Complete Remission in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant ChemotherapyHee Jun Choi, Jun Ho Lee, Chang Shin Jung, Jeong Eon Lee, Youn Joo Jung, Seungju Lee, Seok-Kyung Kang, Hyun Yul Kimhttps://www.karger.com/Article/Pdf/526155, https://www.karger.com/Article/Pdf/526155
The Breast10.1016/s0960-9776(19)30270-x201944S73Validation of Magee equation in predicting response to neoadjuvant chemotherapy in breast cancer patients with hormone receptor positive and HER2 negativeN. Saigosoom, P. O-charoenrat, S. Udompunturak, D. Sanguanraksahttps://api.elsevier.com/content/article/PII:S096097761930270X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S096097761930270X?httpAccept=text/plain
The Breast10.1016/j.breast.2013.12.0052014232188-192Neoadjuvant treatment of HER2 and hormone-receptor positive breast cancer – Moving beyond pathological complete responseSerena Di Cosimo, Grazia Arpino, Daniele Generalihttps://api.elsevier.com/content/article/PII:S0960977613003172?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960977613003172?httpAccept=text/plain
10.21203/rs.3.rs-73479/v12020Estrogen Receptor-negative/progesterone Receptor-positive and Her-2 Negative Breast Cancer Might No Longer Be Classified as Hormone Receptor Positive Breast CancerHongjuan Zheng, Chenyang Ge, Haiping Lin, Lunpo Wu, Qinghua Wang, Shishi Zhou, Wanfen Tang, Xia Zhang, Xiayun Jin, Xifeng Xu, Zhongwu Hong, Jianfei Fu, Jinlin Duhttps://www.researchsquare.com/article/rs-73479/v1, https://www.researchsquare.com/article/rs-73479/v1.html